AT372373B - Verfahren zur herstellung von neuen 4-amino-3chinolincarbonsaeuren, deren estern und salzen - Google Patents
Verfahren zur herstellung von neuen 4-amino-3chinolincarbonsaeuren, deren estern und salzenInfo
- Publication number
- AT372373B AT372373B AT0156480A AT156480A AT372373B AT 372373 B AT372373 B AT 372373B AT 0156480 A AT0156480 A AT 0156480A AT 156480 A AT156480 A AT 156480A AT 372373 B AT372373 B AT 372373B
- Authority
- AT
- Austria
- Prior art keywords
- 3chinoline
- esters
- salts
- amino
- producing new
- Prior art date
Links
- 150000004653 carbonic acids Chemical class 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2398179A | 1979-03-26 | 1979-03-26 | |
| US06/127,153 US4343804A (en) | 1979-03-26 | 1980-03-04 | 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA156480A ATA156480A (de) | 1983-02-15 |
| AT372373B true AT372373B (de) | 1983-09-26 |
Family
ID=26697875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0156480A AT372373B (de) | 1979-03-26 | 1980-03-24 | Verfahren zur herstellung von neuen 4-amino-3chinolincarbonsaeuren, deren estern und salzen |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4343804A (de) |
| JP (1) | JPH02117663A (de) |
| AR (1) | AR230268A1 (de) |
| AT (1) | AT372373B (de) |
| AU (1) | AU528388B2 (de) |
| BR (1) | BR8001779A (de) |
| CA (1) | CA1147338A (de) |
| CH (1) | CH644105A5 (de) |
| DE (1) | DE3011490A1 (de) |
| DK (1) | DK156056C (de) |
| EG (1) | EG15009A (de) |
| ES (1) | ES8103048A1 (de) |
| FI (1) | FI77452C (de) |
| FR (1) | FR2452485B1 (de) |
| GB (1) | GB2047244B (de) |
| GR (1) | GR68006B (de) |
| HK (1) | HK67983A (de) |
| IE (1) | IE49577B1 (de) |
| IL (1) | IL59628A (de) |
| IN (1) | IN151446B (de) |
| IT (1) | IT1133079B (de) |
| MX (1) | MX6264E (de) |
| NL (1) | NL8001752A (de) |
| NO (1) | NO153927C (de) |
| NZ (1) | NZ193252A (de) |
| PH (1) | PH16416A (de) |
| PL (1) | PL125030B1 (de) |
| PT (1) | PT71008B (de) |
| SE (1) | SE435837B (de) |
| SG (1) | SG33683G (de) |
| YU (1) | YU41702B (de) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
| GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
| GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804444D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804447D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804446D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804448D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| US5432182A (en) * | 1989-02-23 | 1995-07-11 | Smithkline Beecham Intercredit B.V. | Compounds substituted quinoline derivatives |
| CA2011086A1 (en) * | 1989-03-17 | 1990-09-17 | Karl-Heinz Geiss | 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom |
| DE3917233A1 (de) * | 1989-05-26 | 1990-11-29 | Basf Ag | 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel |
| GB8918265D0 (en) * | 1989-08-10 | 1989-09-20 | Smithkline Beckman Intercredit | Compounds |
| US5362743A (en) * | 1993-03-09 | 1994-11-08 | Pfizer Inc. | Aminoquinoline derivatives |
| IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
| US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
| WO1995004720A2 (en) * | 1993-08-10 | 1995-02-16 | Black James Foundation | Gastrin and cck receptor ligands |
| US5650415A (en) * | 1995-06-07 | 1997-07-22 | Sugen, Inc. | Quinoline compounds |
| KR0169813B1 (ko) * | 1995-07-12 | 1999-01-15 | 김종인 | 4-아미노-3-아실나프티리딘 유도체 |
| US5760041A (en) * | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
| US6875769B2 (en) * | 1996-05-23 | 2005-04-05 | Pfizer Inc. | Substituted6,6-hetero-bicyclicderivatives |
| US5929080A (en) * | 1997-05-06 | 1999-07-27 | American Cyanamid Company | Method of treating polycystic kidney disease |
| US6251912B1 (en) | 1997-08-01 | 2001-06-26 | American Cyanamid Company | Substituted quinazoline derivatives |
| US6323209B1 (en) | 1997-11-06 | 2001-11-27 | American Cyanamid Company | Method of treating or inhibiting colonic polyps |
| BRPI9914164B8 (pt) | 1998-09-29 | 2021-05-25 | American Cyanamid Co | compostos de 3-ciano quinolina |
| JP4234344B2 (ja) * | 1999-12-28 | 2009-03-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド含有複素環化合物 |
| US6521618B2 (en) | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| US6576644B2 (en) * | 2000-09-06 | 2003-06-10 | Bristol-Myers Squibb Co. | Quinoline inhibitors of cGMP phosphodiesterase |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| CN102558155A (zh) | 2003-01-14 | 2012-07-11 | 阿伦纳药品公司 | 作为代谢调节剂的芳基和杂芳基衍生物及其所涉及的疾病如糖尿病和高血糖症的预防和治疗 |
| KR101179012B1 (ko) | 2003-03-10 | 2012-09-03 | 니코메드 게엠베하 | 로플루미라스트 신규한 제조 방법 |
| RS20060018A (sr) * | 2003-07-14 | 2007-12-31 | Arena Pharmaceuticals Inc., | Derivati spojenih arila i heteroarila kao modulatori metabolizma u profilaksi i lečenju sa njima povezanih stanja |
| EP1861074B1 (de) * | 2005-03-16 | 2013-04-24 | Takeda GmbH | Geschmacksmaskierte dosierform von roflumilast |
| WO2011022216A1 (en) * | 2009-08-17 | 2011-02-24 | High Point Pharmaceuticals, Llc | Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress |
| JP5856980B2 (ja) | 2010-01-27 | 2016-02-10 | アリーナ ファーマシューティカルズ， インコーポレイテッド | （Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸およびその塩の調製のためのプロセス |
| EP3323818A1 (de) | 2010-09-22 | 2018-05-23 | Arena Pharmaceuticals, Inc. | Modulatoren des gpr119-rezeptors und behandlung von damit assoziierten erkrankungen |
| EP4445956A3 (de) | 2015-01-06 | 2024-12-04 | Arena Pharmaceuticals, Inc. | Wirkstoff zur behandlung von mit s1p1-rezeptor zusammenhängenden erkrankungen |
| EP3310760B8 (de) | 2015-06-22 | 2022-10-19 | Arena Pharmaceuticals, Inc. | Kristallines l-argininsalz von (r) -2-(7-(4-cyclopentyl-3-(trifluormethyl) benzyloxy ) -1,2,3,4-tetrahydrocyclo-penta [ b ] indol-3-yl) essigsäure zur verwendung bei s1p1-rezeptor-assozierten erkrankungen |
| ES2884073T3 (es) | 2016-11-11 | 2021-12-10 | Bayer Animal Health Gmbh | Nuevos derivados antihelmínticos de quinolina-3-carboxamida |
| EP3582772A1 (de) | 2017-02-16 | 2019-12-25 | Arena Pharmaceuticals, Inc. | Verbindungen und verfahren zur behandlung von primärer biliärer cholangitis |
| WO2019084271A1 (en) * | 2017-10-25 | 2019-05-02 | Children's Medical Center Corporation | PAPD5 INHIBITORS AND METHODS OF USE |
| DK3790874T3 (da) | 2018-05-09 | 2023-05-15 | Bayer Animal Health Gmbh | Anthelmintiske kinolinderivater |
| KR102859841B1 (ko) | 2018-06-06 | 2025-09-12 | 아레나 파마슈티칼스, 인크. | S1p1 수용체와 관련된 병태의 치료 방법 |
| JP7617020B2 (ja) | 2019-04-24 | 2025-01-17 | チルドレンズ メディカル センター コーポレイション | Ｐａｐｄ５阻害剤およびその使用方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
| JPS4838712A (de) * | 1971-09-18 | 1973-06-07 |
-
1980
- 1980-03-04 US US06/127,153 patent/US4343804A/en not_active Expired - Lifetime
- 1980-03-14 IL IL59628A patent/IL59628A/xx unknown
- 1980-03-22 GR GR61513A patent/GR68006B/el unknown
- 1980-03-24 MX MX808722U patent/MX6264E/es unknown
- 1980-03-24 FI FI800910A patent/FI77452C/fi not_active IP Right Cessation
- 1980-03-24 AT AT0156480A patent/AT372373B/de not_active IP Right Cessation
- 1980-03-24 IE IE605/80A patent/IE49577B1/en unknown
- 1980-03-24 FR FR8006516A patent/FR2452485B1/fr not_active Expired
- 1980-03-25 NZ NZ193252A patent/NZ193252A/en unknown
- 1980-03-25 CH CH234080A patent/CH644105A5/fr not_active IP Right Cessation
- 1980-03-25 NO NO800858A patent/NO153927C/no unknown
- 1980-03-25 DK DK128380A patent/DK156056C/da not_active IP Right Cessation
- 1980-03-25 PL PL1980222993A patent/PL125030B1/pl unknown
- 1980-03-25 ES ES489887A patent/ES8103048A1/es not_active Expired
- 1980-03-25 PT PT71008A patent/PT71008B/pt unknown
- 1980-03-25 EG EG80174A patent/EG15009A/xx active
- 1980-03-25 NL NL8001752A patent/NL8001752A/nl not_active Application Discontinuation
- 1980-03-25 GB GB8009991A patent/GB2047244B/en not_active Expired
- 1980-03-25 PH PH23804A patent/PH16416A/en unknown
- 1980-03-25 BR BR8001779A patent/BR8001779A/pt unknown
- 1980-03-25 IN IN345/CAL/80A patent/IN151446B/en unknown
- 1980-03-25 DE DE19803011490 patent/DE3011490A1/de active Granted
- 1980-03-25 SE SE8002292A patent/SE435837B/sv not_active IP Right Cessation
- 1980-03-26 YU YU844/80A patent/YU41702B/xx unknown
- 1980-03-26 AU AU56848/80A patent/AU528388B2/en not_active Ceased
- 1980-03-26 IT IT67465/80A patent/IT1133079B/it active
- 1980-03-26 CA CA000348417A patent/CA1147338A/en not_active Expired
- 1980-03-26 AR AR280455A patent/AR230268A1/es active
-
1983
- 1983-06-13 SG SG336/83A patent/SG33683G/en unknown
- 1983-12-15 HK HK679/83A patent/HK67983A/xx unknown
-
1989
- 1989-09-26 JP JP1250369A patent/JPH02117663A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT372373B (de) | Verfahren zur herstellung von neuen 4-amino-3chinolincarbonsaeuren, deren estern und salzen | |
| AT375919B (de) | Verfahren zur herstellung von neuen dehydrocyclischen iminosaeuren und deren estern | |
| AT362780B (de) | Verfahren zur herstellung von neuen substituierten aminosaeuren bzw. deren estern und ihren salzen | |
| AT374191B (de) | Verfahren zur herstellung von neuen substituierten acethydroxamsaeuren und deren salzen | |
| AT347922B (de) | Verfahren zur herstellung von neuen benzoesaeuren, deren estern und salzen | |
| AT361121B (de) | Verfahren zur herstellung von neuen 7beta-aryl- malonamido-7alpha-methoxy-3-thiadiazolylthio-1- -oxadethiacephalosporinen und deren estern und salzen mit basen | |
| AT368506B (de) | Verfahren zur herstellung von neuen penemcarbonsaeuren und deren salzen | |
| AT360535B (de) | Verfahren zur herstellung von neuen 1-azaxan- thon-3-carbonsaeuren und deren salzen | |
| AT345798B (de) | Verfahren zur herstellung von neuen phenoxyalkancarbonsaeuren und deren alkylestern | |
| AT348992B (de) | Verfahren zur herstellung von neuen phenylessigsaeuren, deren estern und salzen | |
| AT376968B (de) | Verfahren zur herstellung von neuen auronderivaten und deren salzen und estern | |
| ATA171986A (de) | Verfahren zur herstellung von neuen, in 3-stellung substituierten propenylaminothiazolylcephalosporansaeuren und deren estern | |
| AT341087B (de) | Verfahren zur herstellung von neuen acylaminocephemcarbonsauren und von deren salzen und estern | |
| AT370079B (de) | Verfahren zur herstellung von d-aryloxypropions[uren, deren salzen und estern | |
| AT358566B (de) | Verfahren zur herstellung von neuen 1-naphthyl- essigsaeuren sowie deren estern, amiden und pharmazeutisch vertraeglichen salzen | |
| AT363463B (de) | Verfahren zur herstellung von neuen 5-sulfamoyl-orthanilsaeuren und deren physiologisch vertraeglichen salzen | |
| ATA559976A (de) | Verfahren zur herstellung von neuen 6,11- dihydro-11-oxodibenz(b,e)oxepinalkansaeuren und deren estern sowie deren salzen | |
| AT358013B (de) | Verfahren zur herstellung von neuen aryloxy- alkyl-p-aminobenzoesaeuren, deren salzen und estern | |
| AT351038B (de) | Verfahren zur herstellung von neuen thiadia- zolo-und thiazolo-pyrimidin-carbonsaeuren, - estern und -salzen und von deren salzen | |
| ATA398578A (de) | Verfahren zur herstellung von neuen pyrazoli- dinylestern und von deren salzen | |
| AT366665B (de) | Verfahren zur herstellung von neuen n-isothioureido-phthalimiden und deren salzen | |
| ATA179879A (de) | Verfahren zur herstellung von neuen estern und von deren saeureadditionssalzen | |
| ATA208583A (de) | Verfahren zur herstellung von neuen auronderivaten und deren salzen und estern | |
| ATA85079A (de) | Verfahren zur herstellung von neuen indancarbonsaeuren und deren estern | |
| AT373894B (de) | Verfahren zur herstellung von neuen cephalosporin-antibiotika sowie von deren salzen und estern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |